CDK6 and glioma: UCA1 knockdown inhibits proliferation and migration of glioma cells through miR-193a-mediated downregulation of cyclin-dependent kinase 6 (CDK6), and inactivates the PI3K/AKT pathway by decreasing the expression levels of phosphorylated PI3K and AKT proteins (61).